Skip to content

DOCPHARMA: what changed

BE 0465.350.075Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€581,444
2024 · €1.2m-€624,842
Equity
€36.6m
2024 · €36.0m+€581,444
Cash
-
not filed
Balance sheet total
€48.2m
2024 · €47.2m+€1.0m

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€1.0m

    up €1.0m (+2.2%), from €47.2m to €48.2m

Equity and liabilities
  • Profit (loss) carried forward +€581,444

    up €581,444 (+1.2%), from -€47.3m to -€46.7m

Income statement
  • Financial income -€638,788

    down €638,788 (-37.6%), from €1.7m to €1.1m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €1.2m
Provisions +€1,237
Other operating items -€8,759
Financial income -€638,788
Financial charges +€1,116
Taxes +€20,352
Result 2025 €581,444
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.

Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €47,169,110 €48,203,405 +€1.0m +2.2%
Formation expenses 20 €0 €0 =
Fixed assets 21/28 €0 €0 =
Tangible fixed assets 22/27 €0 €0 =
Furniture and vehicles 24 €0 €0 =
Financial fixed assets 28 €0 €0 =
Affiliated companies 280/1 €0 €0 =
Participating interests 280 €0 €0 =
Current assets 29/58 €47,169,110 €48,203,405 +€1.0m +2.2%
Amounts receivable within one year 40/41 €47,169,110 €48,203,405 +€1.0m +2.2%
Other amounts receivable 41 €47,169,110 €48,203,405 +€1.0m +2.2%
Total equity and liabilities 10/49 €47,169,110 €48,203,405 +€1.0m +2.2%
Equity 10/15 €35,969,736 €36,551,180 +€581,444 +1.6%
Contributions 10/11 €83,290,373 €83,290,373 = 0.0%
Profit (loss) carried forward 14 -€47,320,637 -€46,739,193 +€581,444 +1.2%
Provisions and deferred taxes 16 €11,186,909 €11,638,540 +€451,632 +4.0%
Provisions for liabilities and charges 160/5 €11,186,909 €11,638,540 +€451,632 +4.0%
Other liabilities and charges 164/5 €11,186,909 €11,638,540 +€451,632 +4.0%
Amounts payable 17/49 €12,465 €13,685 +€1,219 +9.8%
Amounts payable within one year 42/48 €12,465 €13,685 +€1,219 +9.8%
Trade debts 44 €12,465 €13,685 +€1,219 +9.8%
Suppliers 440/4 €12,465 €13,685 +€1,219 +9.8%
Other amounts payable 47/48 €0 €0 =
Operating charges 60/66A €469,053 €476,575 +€7,522 +1.6%
Services and other goods 61 €16,184 €24,943 +€8,759 +54.1%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 €452,869 €451,632 -€1,237 -0.3%
Operating profit (loss) 9901 -€469,053 -€476,575 -€7,522 -1.6%
Financial income 75/76B €1,697,570 €1,058,783 -€638,788 -37.6%
Recurring financial income 75 €1,697,570 €1,058,783 -€638,788 -37.6%
Income from current assets 751 €1,697,570 €1,058,783 -€638,788 -37.6%
Other financial income 752/9 €0 €0 =
Financial charges 65/66B €1,880 €764 -€1,116 -59.4%
Recurring financial charges 65 €1,880 €764 -€1,116 -59.4%
Other financial charges 652/9 €1,880 €764 -€1,116 -59.4%
Profit (loss) for the period before taxes 9903 €1,226,638 €581,444 -€645,194 -52.6%
Income taxes 67/77 €20,352 - -€20,352
Taxes 670/3 €20,352 - -€20,352
Profit (loss) for the period 9904 €1,206,286 €581,444 -€624,842 -51.8%
Profit (loss) for the period to be appropriated 9905 €1,206,286 €581,444 -€624,842 -51.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€21.3m to €22.6m

Midpoint €21.9m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €36.6m
Capitalised earnings €6.1m to €8.6m
Indication €21.3m to €22.6m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€36,551,180
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€36.6m

Capitalised earnings

net result for the year (9904)
2025
€581,444
2024
€1,206,286
2023
€788,648
2022
€1,235,917
excluding non-recurring income and charges
-€425,868
2021
-€466,245
Average result
€858,793
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€6.1m / €7.2m / €8.6m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.